Arcadia Biosciences Overview
Arcadia Biosciences (RKDA) has a ROE of -323.15%, below the Materials sector average of 19.3%.
Get informed when a big investor buys or sells
+ Follow-323.15%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, RKDA shows a ROE of -323.15%. That is below the Materials sector average of 19.3%. Scroll down for historical charts and peer comparison views.
The Materials sector average ROE is about 19.3%. Arcadia Biosciences is at -323.15%, which is lower that average. That is roughly 1774.3% below the sector mean. Use the comparison chart on this page to see how RKDA stacks up against individual peers as well.
Check the historical chart to see whether RKDA's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Arcadia Biosciences with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Arcadia Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -323.15%) with ownership activity and broader fundamentals.
The Materials average ROE is about 19.3%, while RKDA is at -323.15%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
